{"id":152,"date":"2026-11-06T02:56:22","date_gmt":"2026-11-06T02:56:22","guid":{"rendered":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/"},"modified":"2026-11-06T04:52:23","modified_gmt":"2026-11-06T04:52:23","slug":"semaglutide-5-mg-cz","status":"publish","type":"product","link":"https:\/\/volo-peptides.com\/en\/produkt\/semaglutide-5-mg\/","title":{"rendered":"Semaglutide 5 mg"},"content":{"rendered":"<article lang=\"cs\">\n<p><strong>Semaglutide 5 mg<\/strong> zna\u010dky VOLO souvis\u00ed s jednou z nejzn\u00e1m\u011bj\u0161\u00edch molekul pro regulaci chuti k j\u00eddlu a t\u011blesn\u00e9 hmotnosti. Semaglutid p\u016fsob\u00ed na receptor GLP-1 a u schv\u00e1len\u00fdch l\u00e9\u010div pom\u00e1h\u00e1 zv\u00fd\u0161it pocit sytosti, omezit hlad a sn\u00ed\u017eit p\u0159\u00edjem potravy. Pokud v\u00e1s zaj\u00edm\u00e1, pro\u010d se o n\u011bm tolik mluv\u00ed p\u0159i hubnut\u00ed, odpov\u011b\u010f je konkr\u00e9tn\u00ed: jeho p\u0159\u00ednosy potvrzuj\u00ed klinick\u00e9 studie. Stejn\u011b d\u016fle\u017eit\u00e9 je v\u0161ak v\u011bd\u011bt, pro koho jsou tyto v\u00fdsledky relevantn\u00ed a jak\u00e1 rizika s molekulou souvisej\u00ed.<\/p>\n<h2>Semaglutid, hlad a sytost: jak\u00e1 je souvislost?<\/h2>\n<p>Semaglutid p\u016fsob\u00ed na receptor GLP-1 a u schv\u00e1len\u00e9ho l\u00e9\u010div\u00e9ho p\u0159\u00edpravku souvis\u00ed s regulac\u00ed hladu a sytosti; to nepotvrzuje vlastnosti konkr\u00e9tn\u00edho v\u00fdzkumn\u00e9ho balen\u00ed.<\/p>\n<p>Pokud m\u00e1te pocit, \u017ee t\u00e9ma hmotnosti se neust\u00e1le zjednodu\u0161uje na v\u016fli a velikost porc\u00ed, semaglutid ukazuje v\u00fdznam hormon\u00e1ln\u00ed regulace. GLP-1 pat\u0159\u00ed k sign\u00e1l\u016fm, kter\u00fdmi organismus reaguje na j\u00eddlo. Semaglutid tuto komunikaci napodobuje a ovliv\u0148uje pocit hladu i dostatku potravy. U registrovan\u00e9ho p\u0159\u00edpravku Wegovy EMA popisuje sn\u00ed\u017een\u00ed hladu, chut\u00ed a p\u0159\u00edjmu energie.<\/p>\n<p>Pr\u00e1v\u011b to je hlavn\u00ed d\u016fvod z\u00e1jmu o tuto molekulu. Nejde o p\u0159\u00edm\u00e9 rozpou\u0161t\u011bn\u00ed tuku ani o l\u00e1tku, kter\u00e1 by odstranila v\u0161echny p\u0159\u00ed\u010diny nadv\u00e1hy. P\u0159\u00ednos spo\u010d\u00edv\u00e1 v ovlivn\u011bn\u00ed regula\u010dn\u00edch sign\u00e1l\u016f, kter\u00e9 mohou m\u00edt pro stravov\u00e1n\u00ed z\u00e1sadn\u00ed v\u00fdznam. Semaglutid se nav\u00edc pou\u017e\u00edv\u00e1 v registrovan\u00fdch l\u00e9\u010divech tak\u00e9 v kontextu diabetu 2. typu. Kontrola krevn\u00edho cukru a \u0159\u00edzen\u00ed hmotnosti spolu souvisej\u00ed, ale nejsou tot\u00e9\u017e.<\/p>\n<h2>\u00da\u010dinnost semaglutidu: co uk\u00e1zala studie STEP 1?<\/h2>\n<p>Studie STEP 1 dolo\u017eila v\u011bt\u0161\u00ed pr\u016fm\u011brn\u00fd pokles hmotnosti se zkouman\u00fdm l\u00e9\u010divem obsahuj\u00edc\u00edm semaglutid ne\u017e s placebem; neov\u011b\u0159ovala tuto v\u00fdzkumnou lahvi\u010dku VOLO.<\/p>\n<p>Ve studii STEP 1 bylo za\u0159azeno 1 961 dosp\u011bl\u00fdch s obezitou nebo s nadv\u00e1hou a p\u0159idru\u017een\u00fdm zdravotn\u00edm probl\u00e9mem, kte\u0159\u00ed nem\u011bli diabetes. Po 68 t\u00fddnech \u010dinila pr\u016fm\u011brn\u00e1 zm\u011bna hmotnosti <strong>\u221214,9 % p\u0159i semaglutidu oproti \u22122,4 % p\u0159i placebu<\/strong>. Ob\u011b skupiny z\u00e1rove\u0148 m\u011bly podporu zam\u011b\u0159enou na stravu a pohyb. Tento v\u00fdsledek pom\u00e1h\u00e1 pochopit, pro\u010d je semaglutid pova\u017eov\u00e1n za v\u00fdznamnou molekulu v l\u00e9\u010db\u011b obezity.<\/p>\n<h3>Co z v\u00fdsledku m\u016f\u017eete vyvodit<\/h3>\n<p>Data ukazuj\u00ed skute\u010dn\u00fd p\u0159\u00ednos zkouman\u00e9ho l\u00e9\u010diva v konkr\u00e9tn\u00ed skupin\u011b pacient\u016f. Neznamenaj\u00ed, \u017ee ka\u017ed\u00fd \u010dlov\u011bk zhubne stejn\u011b nebo \u017ee se v\u00fdsledek dostav\u00ed rychle. Hodnocen\u00ed prob\u00edhalo d\u00e9le ne\u017e rok, nikoli b\u011bhem n\u011bkolika dn\u016f. Rozd\u00edly mezi jednotlivci z\u016fst\u00e1vaj\u00ed d\u016fle\u017eit\u00e9 i tehdy, kdy\u017e je pr\u016fm\u011brn\u00fd v\u00fdsledek p\u0159esv\u011bd\u010div\u00fd.<\/p>\n<h4>Pro\u010d pr\u016fm\u011br nen\u00ed osobn\u00ed slib<\/h4>\n<p>Pr\u016fm\u011br shrnuje celou skupinu. N\u011bkte\u0159\u00ed \u00fa\u010dastn\u00edci dos\u00e1hli v\u011bt\u0161\u00ed zm\u011bny, jin\u00ed men\u0161\u00ed a \u010d\u00e1st l\u00e9\u010dbu nedokon\u010dila. P\u0159i zva\u017eov\u00e1n\u00ed p\u0159\u00ednosu m\u00e1 proto smysl spojit \u00fa\u010dinnost se sn\u00e1\u0161enlivost\u00ed a celkov\u00fdm zdravotn\u00edm stavem. Samotn\u00e9 procento v\u00e1m neposkytne \u00fapln\u00fd obraz.<\/p>\n<h2>Jak funguje jednodu\u0161e<\/h2>\n<p>Semaglutid aktivuje receptor GLP-1. T\u00edm ovliv\u0148uje signalizaci souvisej\u00edc\u00ed s hladem, sytost\u00ed a regulac\u00ed gluk\u00f3zy. U schv\u00e1len\u00fdch p\u0159\u00edpravk\u016f pom\u00e1h\u00e1 p\u0159i zv\u00fd\u0161en\u00e9 gluk\u00f3ze podpo\u0159it odpov\u011b\u010f inzulinu a tlumit glukagon; zpomalen\u00ed vyprazd\u0148ov\u00e1n\u00ed \u017ealudku je dal\u0161\u00ed souvisej\u00edc\u00ed \u00fa\u010dinek. Jednodu\u0161e \u0159e\u010deno: m\u011bn\u00ed zp\u016fsob, jak\u00fdm t\u011blo vyhodnocuje n\u011bkter\u00e9 sign\u00e1ly kolem j\u00eddla. Nen\u00ed to inzulin ani univerz\u00e1ln\u00ed spalova\u010d tuku.<\/p>\n<h2>Hlavn\u00ed plusy molekuly v p\u0159ehledu<\/h2>\n<ul>\n<li><strong>Prok\u00e1zan\u00fd vliv na \u0159\u00edzen\u00ed hmotnosti:<\/strong> u konkr\u00e9tn\u00edch schv\u00e1len\u00fdch p\u0159\u00edpravk\u016f a vymezen\u00fdch pacientsk\u00fdch skupin existuj\u00ed kvalitn\u00ed klinick\u00e9 podklady, nikoli pouze osobn\u00ed zku\u0161enosti.<\/li>\n<li><strong>Vztah k hladu a sytosti:<\/strong> mechanismus \u0159e\u0161\u00ed d\u016fle\u017eitou \u010d\u00e1st regulace p\u0159\u00edjmu potravy, co\u017e vysv\u011btluje jeho praktick\u00fd v\u00fdznam v l\u00e9\u010db\u011b obezity.<\/li>\n<li><strong>Souvislost s gluk\u00f3zovou regulac\u00ed:<\/strong> semaglutid m\u00e1 v\u00fdznam tak\u00e9 v registrovan\u00fdch l\u00e9\u010divech pro diabetes 2. typu, podle jejich konkr\u00e9tn\u00edho schv\u00e1len\u00e9ho pou\u017eit\u00ed.<\/li>\n<li><strong>Dob\u0159e dostupn\u00e9 informace:<\/strong> m\u016f\u017eete si ov\u011b\u0159it p\u0159\u00ednosy i rizika v p\u016fvodn\u00edch studi\u00edch a aktu\u00e1ln\u00ed dokumentaci EMA a rozhodovat se na z\u00e1klad\u011b konkr\u00e9tn\u00edch \u00fadaj\u016f.<\/li>\n<\/ul>\n<h2>Vedlej\u0161\u00ed \u00fa\u010dinky: co je \u010dast\u00e9 a co u\u017e vy\u017eaduje pozornost<\/h2>\n<p>Mezi \u010dast\u00e9 obt\u00ed\u017ee pat\u0159\u00ed nevolnost, zvracen\u00ed, pr\u016fjem, z\u00e1cpa a bolest b\u0159icha. Mohou ovlivnit b\u011b\u017en\u00e9 fungov\u00e1n\u00ed, p\u0159esto\u017ee b\u00fdvaj\u00ed \u010dasto m\u00edrn\u00e9 nebo st\u0159edn\u00ed. Zvracen\u00ed a pr\u016fjem mohou v\u00e9st k dehydrataci a n\u00e1sledn\u011b ke zhor\u0161en\u00ed funkce ledvin. Men\u0161\u00ed chu\u0165 k j\u00eddlu proto nelze automaticky hodnotit jako p\u0159\u00ednos, pokud je spojena s v\u00fdraznou nevolnost\u00ed nebo ztr\u00e1tou tekutin.<\/p>\n<p>Mezi d\u016fle\u017eit\u00e1 z\u00e1va\u017en\u011bj\u0161\u00ed rizika pat\u0159\u00ed akutn\u00ed pankreatitida a probl\u00e9my se \u017elu\u010dn\u00edkem. U n\u011bkter\u00fdch lid\u00ed s diabetem m\u016f\u017ee doj\u00edt ke zhor\u0161en\u00ed diabetick\u00e9 retinopatie. EMA tak\u00e9 potvrdila <strong>NAION, poruchu prokrven\u00ed zrakov\u00e9ho nervu, jako velmi vz\u00e1cn\u00fd ne\u017e\u00e1douc\u00ed \u00fa\u010dinek<\/strong>, kter\u00fd m\u016f\u017ee postihnout a\u017e jednoho z 10 000 lid\u00ed. N\u00e1hl\u00e1 ztr\u00e1ta nebo rychl\u00e9 zhor\u0161en\u00ed zraku vy\u017eaduje bezodkladn\u00e9 l\u00e9ka\u0159sk\u00e9 vy\u0161et\u0159en\u00ed.<\/p>\n<p>Z\u00e1va\u017en\u00e1 p\u0159etrv\u00e1vaj\u00edc\u00ed bolest b\u0159icha, v\u00fdrazn\u00e9 zvracen\u00ed nebo zn\u00e1mky alergick\u00e9 reakce nejsou situace k p\u0159ehl\u00ed\u017een\u00ed. \u00dapln\u00e9 posouzen\u00ed rizik pat\u0159\u00ed ke konkr\u00e9tn\u00edmu registrovan\u00e9mu p\u0159\u00edpravku a zdravotn\u00edmu stavu, ne pouze k n\u00e1zvu molekuly.<\/p>\n<h2>Kdo mus\u00ed b\u00fdt zvl\u00e1\u0161\u0165 opatrn\u00fd<\/h2>\n<ul>\n<li><strong>Lid\u00e9 s p\u0159ecitliv\u011blost\u00ed:<\/strong> alergie na semaglutid nebo slo\u017eky konkr\u00e9tn\u00edho l\u00e9\u010diva pat\u0159\u00ed mezi kontraindikace dan\u00e9ho p\u0159\u00edpravku.<\/li>\n<li><strong>Lid\u00e9 s d\u0159\u00edv\u011bj\u0161\u00ed pankreatitidou nebo z\u00e1va\u017en\u00fdmi tr\u00e1vic\u00edmi obt\u00ed\u017eemi:<\/strong> v\u00fdznamn\u00e1 je zejm\u00e9na t\u011b\u017ek\u00e1 gastropar\u00e9za, tedy v\u00fdrazn\u011b zpomalen\u00e9 vyprazd\u0148ov\u00e1n\u00ed \u017ealudku.<\/li>\n<li><strong>Pacienti s diabetickou retinopati\u00ed:<\/strong> rychl\u00e1 zm\u011bna glykemie m\u016f\u017ee ovlivnit o\u010dn\u00ed komplikace a vy\u017eaduje odborn\u00e9 sledov\u00e1n\u00ed.<\/li>\n<li><strong>U\u017eivatel\u00e9 inzulinu nebo sulfonylurey:<\/strong> p\u0159i kombinaci m\u016f\u017ee nar\u016fstat riziko hypoglykemie. O soub\u011b\u017en\u00e9 l\u00e9\u010db\u011b mus\u00ed v\u011bd\u011bt l\u00e9ka\u0159.<\/li>\n<li><strong>T\u011bhotn\u00e9 a koj\u00edc\u00ed \u017eeny:<\/strong> dokumentace Wegovy uv\u00e1d\u00ed, \u017ee se semaglutid b\u011bhem t\u011bhotenstv\u00ed a kojen\u00ed nem\u00e1 pou\u017e\u00edvat.<\/li>\n<li><strong>Lid\u00e9 p\u0159ed anestezi\u00ed nebo hlubokou sedac\u00ed:<\/strong> zpomalen\u00e9 vyprazd\u0148ov\u00e1n\u00ed \u017ealudku souvis\u00ed s rizikem vdechnut\u00ed \u017ealude\u010dn\u00edho obsahu; zdravotn\u00edci o l\u00e9\u010db\u011b pot\u0159ebuj\u00ed v\u011bd\u011bt.<\/li>\n<\/ul>\n<h2>Co znamen\u00e1 Semaglutide 5 mg jako produkt VOLO<\/h2>\n<p>Tato varianta uv\u00e1d\u00ed deklarovan\u00fd obsah 5 mg semaglutidu a m\u00e1 ur\u010den\u00ed <strong>research use only<\/strong>. Nejde o Ozempic ani Wegovy a nen\u00ed ur\u010dena k samol\u00e9\u010db\u011b nebo pod\u00e1v\u00e1n\u00ed lidem. V\u00fdsledky klinick\u00fdch studi\u00ed neov\u011b\u0159uj\u00ed obsah tohoto balen\u00ed. \u010c\u00edslo 5 mg ozna\u010duje celkov\u00e9 deklarovan\u00e9 mno\u017estv\u00ed, nikoli osobn\u00ed d\u00e1vku. Specifikaci a dolo\u017een\u00e9 vlastnosti konkr\u00e9tn\u00edho produktu posuzujte samostatn\u011b.<\/p>\n<h2>Semaglutid, tirzepatid nebo retatrutid?<\/h2>\n<p>Semaglutid m\u00e1 profil GLP-1, tirzepatid kombinuje GIP a GLP-1 a retatrutid p\u0159id\u00e1v\u00e1 tak\u00e9 glukagonov\u00fd receptor. V\u00edce c\u00edl\u016f neznamen\u00e1 automaticky vhodn\u011bj\u0161\u00ed volbu pro ka\u017ed\u00e9ho. Li\u0161\u00ed se klinick\u00e9 podklady, rizika i regula\u010dn\u00ed status. Retatrutid z\u016fst\u00e1v\u00e1 experiment\u00e1ln\u00ed, zat\u00edmco semaglutid a tirzepatid jsou \u00fa\u010dinn\u00fdmi l\u00e1tkami registrovan\u00fdch l\u00e9\u010div. P\u0159\u00edm\u00e9 zdravotn\u00ed rozhodnut\u00ed v\u017edy pot\u0159ebuje \u0161ir\u0161\u00ed posouzen\u00ed ne\u017e porovn\u00e1n\u00ed n\u00e1zv\u016f.<\/p>\n<h2>Praktick\u00e9 ot\u00e1zky p\u0159ed rozhodnut\u00edm<\/h2>\n<h3>Pom\u016f\u017ee semaglutid ka\u017ed\u00e9mu zhubnout stejn\u011b?<\/h3>\n<p>Ne. Klinick\u00e9 pr\u016fm\u011bry popisuj\u00ed skupinu, nikoli osobn\u00ed z\u00e1ruku. Rozhoduj\u00ed zdravotn\u00ed okolnosti, sn\u00e1\u0161enlivost i podm\u00ednky l\u00e9\u010dby. Relevantn\u00ed je z\u00e1rove\u0148 to, zda \u010dlov\u011bk v\u016fbec odpov\u00edd\u00e1 schv\u00e1len\u00e9mu pou\u017eit\u00ed konkr\u00e9tn\u00edho l\u00e9ku.<\/p>\n<h3>Je men\u0161\u00ed hlad jedin\u00fd d\u016fle\u017eit\u00fd \u00fa\u010dinek?<\/h3>\n<p>Nen\u00ed. Semaglutid souvis\u00ed i s gluk\u00f3zovou regulac\u00ed a vyprazd\u0148ov\u00e1n\u00edm \u017ealudku. Pr\u00e1v\u011b \u0161ir\u0161\u00ed souvislosti vysv\u011btluj\u00ed jak p\u0159\u00ednos, tak \u010d\u00e1st ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f. \u00da\u010dinnost a bezpe\u010dnost m\u00e1 proto smysl \u010d\u00edst spole\u010dn\u011b.<\/p>\n<h3>Je p\u0159\u00edrodn\u00ed hormon\u00e1ln\u00ed mechanismus z\u00e1rukou bezpe\u010dnosti?<\/h3>\n<p>Nen\u00ed. L\u00e1tka m\u016f\u017ee vyu\u017e\u00edvat p\u0159irozenou sign\u00e1ln\u00ed dr\u00e1hu a sou\u010dasn\u011b m\u00edt v\u00fdznamn\u00e1 rizika. U\u017eite\u010dn\u011bj\u0161\u00ed ne\u017e ozna\u010den\u00ed \u201ep\u0159irozen\u00e9\u201c je v\u011bd\u011bt, jak\u00fd p\u0159\u00ednos byl dolo\u017een a pro koho mohou b\u00fdt vedlej\u0161\u00ed \u00fa\u010dinky zvl\u00e1\u0161\u0165 d\u016fle\u017eit\u00e9.<\/p>\n<h3>Pro\u010d se \u00fa\u010dinnost hodnot\u00ed spole\u010dn\u011b se stravou a pohybem?<\/h3>\n<p>Ve studii STEP 1 dost\u00e1valy ob\u011b skupiny podporu \u017eivotn\u00edho stylu. V\u00fdsledek tedy popisuje tento celkov\u00fd p\u0159\u00edstup, ne izolovan\u00fd slib bez dal\u0161\u00edch souvislost\u00ed. Pokud chcete p\u0159\u00ednos spr\u00e1vn\u011b pochopit, vn\u00edmejte molekulu jako sou\u010d\u00e1st l\u00e9\u010debn\u00e9ho kontextu. D\u016fle\u017eit\u00e9 je tak\u00e9 udr\u017een\u00ed zm\u011bny v \u010dase: kr\u00e1tk\u00fd pokles hmotnosti a dlouhodob\u011b p\u0159ijateln\u00fd v\u00fdvoj nejsou toto\u017en\u00e9 c\u00edle. Pr\u00e1v\u011b proto m\u00e1 v\u00fdznam vedle \u00fa\u010dinnosti mluvit o sn\u00e1\u0161enlivosti, ka\u017edodenn\u00edm fungov\u00e1n\u00ed, zdravotn\u00edch priorit\u00e1ch a tom, co \u010dlov\u011bk od ov\u011b\u0159en\u00e9 l\u00e9\u010dby realisticky o\u010dek\u00e1v\u00e1.<\/p>\n<h2>Vyberte si informace, kter\u00e9 maj\u00ed skute\u010dnou hodnotu<\/h2>\n<p>Porovnejte o\u010dek\u00e1van\u00e9 p\u0159\u00ednosy s riziky, ov\u011b\u0159te p\u0159esnou specifikaci produktu a rozli\u0161ujte v\u00fdzkumn\u00fd materi\u00e1l od registrovan\u00e9 l\u00e9\u010dby. Pokud \u0159e\u0161\u00edte vlastn\u00ed hmotnost nebo diabetes, vyu\u017eijte tyto informace pro v\u011bcnou konzultaci s l\u00e9ka\u0159em. Dobr\u00e9 rozhodnut\u00ed stoj\u00ed na porozum\u011bn\u00ed, nikoli na samotn\u00e9m slibu rychl\u00e9 zm\u011bny.<\/p>\n<h2>Odborn\u00e9 zdroje<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183\">NEJM: STEP 1 \u2013 semaglutid u dosp\u011bl\u00fdch s nadv\u00e1hou nebo obezitou<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/wegovy\">EMA: Wegovy \u2013 schv\u00e1len\u00e9 pou\u017eit\u00ed a p\u0159\u00ednosy<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/wegovy-epar-product-information_en.pdf\">EMA: aktu\u00e1ln\u00ed odborn\u00e1 dokumentace Wegovy<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy\">EMA: NAION jako velmi vz\u00e1cn\u00fd ne\u017e\u00e1douc\u00ed \u00fa\u010dinek semaglutidu<\/a><\/li>\n<\/ul>\n<h2>Semaglutide, Tirzepatide a Retatrutide: jak se li\u0161\u00ed?<\/h2>\n<p>Semaglutid, <a href=\"\/produkt\/tirzepatide-10-mg-cz\/\">Tirzepatide 10 mg<\/a> a <a href=\"\/produkt\/retatrutide-10mg-cz\/\">Retatrutide 10 mg<\/a> ozna\u010duj\u00ed r\u016fzn\u00e9 molekuly s odli\u0161n\u00fdmi receptorov\u00fdmi profily a v\u00fdzkumn\u00fdmi podklady. Porovn\u00e1vejte jejich mechanismus, typ studie a regula\u010dn\u00ed status; samotn\u00e9 mno\u017estv\u00ed v miligramech nen\u00ed spole\u010dnou stupnic\u00ed \u00fa\u010dinnosti. V\u00fdzkumn\u00e9 produkty nelze zam\u011b\u0148ovat za registrovan\u00e1 l\u00e9\u010diva.<\/p>\n<p>Jak odd\u011blit klinick\u00e9 v\u00fdsledky od vlastnost\u00ed dodan\u00e9ho balen\u00ed vysv\u011btluje <a href=\"\/pruvodce-vyzkumnymi-produkty\/\">pr\u016fvodce v\u00fdzkumn\u00fdmi produkty<\/a>. Jde o porovn\u00e1n\u00ed informac\u00ed, nikoli doporu\u010den\u00ed l\u00e9\u010dby nebo kombinace.<\/p>\n<\/article>\n","protected":false},"excerpt":{"rendered":"<p>Semaglutide 5 mg VOLO is a research product. The declared quantity is the contents of the container, not a dose. For research use only; not for administration to humans.<\/p>\n","protected":false},"featured_media":161,"comment_status":"open","ping_status":"closed","template":"","meta":{"_latwm_translated_slug":""},"product_brand":[28],"product_cat":[15],"product_tag":[],"class_list":["post-152","product","type-product","status-publish","has-post-thumbnail","product_brand-volo","product_cat-vyzkumne-produkty","first","instock","shipping-taxable","product-type-simple"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky<\/title>\n<meta name=\"description\" content=\"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky\" \/>\n<meta property=\"og:description\" content=\"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/\" \/>\n<meta property=\"og:site_name\" content=\"VOLO\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-06T04:52:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/Semaglutide-5-mg-VOLO.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"961\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/\",\"url\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/\",\"name\":\"Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/volo-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Semaglutide-5-mg-VOLO.webp\",\"datePublished\":\"2026-11-06T02:56:22+00:00\",\"dateModified\":\"2026-11-06T04:52:23+00:00\",\"description\":\"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/#primaryimage\",\"url\":\"https:\\\/\\\/volo-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Semaglutide-5-mg-VOLO.webp\",\"contentUrl\":\"https:\\\/\\\/volo-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Semaglutide-5-mg-VOLO.webp\",\"width\":1600,\"height\":961,\"caption\":\"VOLO Semaglutide 5 mg vial for research use only\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/produkt\\\/semaglutide-5-mg-cz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/volo-peptides.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"V\u00fdzkumn\u00e9 peptidy VOLO\",\"item\":\"https:\\\/\\\/volo-peptides.com\\\/produkty\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Semaglutide 5 mg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#website\",\"url\":\"https:\\\/\\\/volo-peptides.com\\\/\",\"name\":\"VOLO\",\"description\":\"V\u00fdzkumn\u00e9 peptidy VOLO: produkty, deklarovan\u00fd obsah a odborn\u00e9 informace.\",\"publisher\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/volo-peptides.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#organization\",\"name\":\"eMarkest, s.r.o.\",\"alternateName\":\"VOLO\",\"url\":\"https:\\\/\\\/volo-peptides.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/volo-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/LOGO-01-scaled.png\",\"contentUrl\":\"https:\\\/\\\/volo-peptides.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/LOGO-01-scaled.png\",\"width\":2560,\"height\":1280,\"caption\":\"eMarkest, s.r.o.\"},\"image\":{\"@id\":\"https:\\\/\\\/volo-peptides.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky","description":"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky","og_description":"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.","og_url":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/","og_site_name":"VOLO","article_modified_time":"2026-11-06T04:52:23+00:00","og_image":[{"width":1600,"height":961,"url":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/Semaglutide-5-mg-VOLO.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/","url":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/","name":"Semaglutide 5 mg: p\u0159\u00ednosy, \u00fa\u010dinnost a vedlej\u0161\u00ed \u00fa\u010dinky","isPartOf":{"@id":"https:\/\/volo-peptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/#primaryimage"},"image":{"@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/#primaryimage"},"thumbnailUrl":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/Semaglutide-5-mg-VOLO.webp","datePublished":"2026-11-06T02:56:22+00:00","dateModified":"2026-11-06T04:52:23+00:00","description":"Co semaglutid skute\u010dn\u011b dok\u00e1\u017ee pro hlad a hmotnost? Poznejte \u00fa\u010dinnost, re\u00e1ln\u00e1 o\u010dek\u00e1v\u00e1n\u00ed, \u010dast\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky i d\u016fle\u017eit\u00e1 rizika Semaglutide 5 mg.","breadcrumb":{"@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/#primaryimage","url":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/Semaglutide-5-mg-VOLO.webp","contentUrl":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/Semaglutide-5-mg-VOLO.webp","width":1600,"height":961,"caption":"VOLO Semaglutide 5 mg vial for research use only"},{"@type":"BreadcrumbList","@id":"https:\/\/volo-peptides.com\/produkt\/semaglutide-5-mg-cz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/volo-peptides.com\/en\/"},{"@type":"ListItem","position":2,"name":"V\u00fdzkumn\u00e9 peptidy VOLO","item":"https:\/\/volo-peptides.com\/produkty\/"},{"@type":"ListItem","position":3,"name":"Semaglutide 5 mg"}]},{"@type":"WebSite","@id":"https:\/\/volo-peptides.com\/#website","url":"https:\/\/volo-peptides.com\/","name":"VOLO","description":"V\u00fdzkumn\u00e9 peptidy VOLO: produkty, deklarovan\u00fd obsah a odborn\u00e9 informace.","publisher":{"@id":"https:\/\/volo-peptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/volo-peptides.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/volo-peptides.com\/#organization","name":"eMarkest, s.r.o.","alternateName":"VOLO","url":"https:\/\/volo-peptides.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/volo-peptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/LOGO-01-scaled.png","contentUrl":"https:\/\/volo-peptides.com\/wp-content\/uploads\/2026\/11\/LOGO-01-scaled.png","width":2560,"height":1280,"caption":"eMarkest, s.r.o."},"image":{"@id":"https:\/\/volo-peptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/product\/152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/comments?post=152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/media\/161"}],"wp:attachment":[{"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/media?parent=152"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/product_brand?post=152"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/product_cat?post=152"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/volo-peptides.com\/en\/wp-json\/wp\/v2\/product_tag?post=152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}